Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement
Anavex Life Sciences is Pleased to Regain Full Compliance with Nasdaq, Continues to Execute on Clinical Development Strategy and Advance all Three Core Indications Forward Anavex Life Sciences is Pleased to Regain Full Compliance with Nasdaq, Continues to Execute on Clinical Development Strategy and Advance all Three Core Indications Forward
Covered in this story
What has happened since
- Nasdaq, Inc. is up 0.4% since this was published, 49 days ago.
- Anavex Life Sciences Corp is down 52.9% since this was published, 49 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $NDAQ yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nasdaq, Inc. →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.